Trade Akoya Biosciences, Inc. - AKYA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.91 |
Open | 2.87 |
1-Year Change | -33.41% |
Day's Range | 2.72 - 2.87 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 13, 2024 | 2.91 | 0.11 | 3.93% | 2.80 | 2.94 | 2.80 |
Sep 12, 2024 | 2.79 | 0.21 | 8.14% | 2.58 | 2.86 | 2.54 |
Sep 11, 2024 | 2.60 | 0.01 | 0.39% | 2.59 | 2.63 | 2.49 |
Sep 10, 2024 | 2.62 | 0.33 | 14.41% | 2.29 | 2.67 | 2.27 |
Sep 9, 2024 | 2.37 | 0.02 | 0.85% | 2.35 | 2.39 | 2.33 |
Sep 6, 2024 | 2.34 | 0.02 | 0.86% | 2.32 | 2.39 | 2.30 |
Sep 5, 2024 | 2.35 | 0.01 | 0.43% | 2.34 | 2.37 | 2.25 |
Sep 4, 2024 | 2.32 | -0.02 | -0.85% | 2.34 | 2.38 | 2.28 |
Sep 3, 2024 | 2.35 | -0.13 | -5.24% | 2.48 | 2.60 | 2.34 |
Aug 30, 2024 | 2.52 | -0.08 | -3.08% | 2.60 | 2.67 | 2.44 |
Aug 29, 2024 | 2.61 | 0.02 | 0.77% | 2.59 | 2.65 | 2.52 |
Aug 28, 2024 | 2.54 | 0.07 | 2.83% | 2.47 | 2.56 | 2.39 |
Aug 27, 2024 | 2.45 | 0.02 | 0.82% | 2.43 | 2.45 | 2.32 |
Aug 26, 2024 | 2.45 | -0.09 | -3.54% | 2.54 | 2.62 | 2.44 |
Aug 23, 2024 | 2.55 | 0.23 | 9.91% | 2.32 | 2.56 | 2.32 |
Aug 22, 2024 | 2.34 | -0.01 | -0.43% | 2.35 | 2.41 | 2.31 |
Aug 21, 2024 | 2.38 | -0.03 | -1.24% | 2.41 | 2.41 | 2.30 |
Aug 20, 2024 | 2.39 | -0.07 | -2.85% | 2.46 | 2.51 | 2.33 |
Aug 19, 2024 | 2.42 | 0.13 | 5.68% | 2.29 | 2.46 | 2.29 |
Aug 16, 2024 | 2.27 | 0.12 | 5.58% | 2.15 | 2.28 | 2.10 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Akoya Biosciences, Inc. Company profile
About Akoya Biosciences Inc
Akoya Biosciences, Inc. is a life sciences technology company. The Company deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. It offers contract research services laboratory, which is called as advanced biopharma solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Akoya Biosciences Inc revenues increased 29% to $54.9M. Net loss applicable to common stockholders increased from $21.8M to $44.4M. Revenues reflect Consumables segment increase of 68% to $14.3M, Instruments segment increase of 21% to $28.7M, North America segment increase of 39% to $28M, EMEA segment increase of 21% to $14.4M. Higher net loss reflects Selling.
Industry: | Advanced Medical Equipment & Technology (NEC) |
100 Campus Drive
6th Floor
MARLBOROUGH
MASSACHUSETTS 01762
US
News
FOMC Decision Preview
As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.
09:48, 16 September 2024ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com